Michael is a Chambers USA-ranked lead trial lawyer with significant victories at virtually every stage of litigation. With a global practice, Michael is a full-service strategic advisor for prominent life sciences and high-tech companies. Building upon long-term relationships of trust, Michael is called upon to take the lead on business-critical matters involving IP and related complex commercial disputes.
With new precedent-setting decisions coming down in 2023 and 2024, the IP litigation landscape continues to evolve. Against this backdrop, Michael serves as lead counsel and strategic advisor on numerous matters impacted by those recent decisions. Further, Michael helps clients understand the IP implications of major legislation and regulations such as the Inflation Reduction Act (IRA) and President Biden’s AI Executive Order.